Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.576
+0.028 (5.11%)
At close: Dec 20, 2024, 4:00 PM
0.579
+0.003 (0.59%)
After-hours: Dec 20, 2024, 7:23 PM EST
Athira Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 22 | 92 | 120 | 487 | 1,113 | - | |
| Market Cap Growth | -77.70% | -22.89% | -75.36% | -56.26% | - | - | |
| Enterprise Value | -45 | -79 | -99 | 253 | 887 | - | |
| Last Close Price | 0.58 | 2.43 | 3.17 | 13.03 | 34.25 | - | |
| PB Ratio | 0.39 | 0.71 | 0.51 | 1.52 | 4.06 | - | |
| P/TBV Ratio | 0.30 | 0.71 | 0.51 | 1.52 | 4.06 | - | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | -0.58 | |
| Quick Ratio | 2.54 | 5.17 | 9.41 | 27.56 | 42.22 | 1.62 | |
| Current Ratio | 2.95 | 5.37 | 9.68 | 28.07 | 43.66 | 1.70 | |
| Return on Equity (ROE) | -102.87% | -64.42% | -34.39% | -18.43% | -14.69% | - | |
| Return on Assets (ROA) | -51.60% | -37.97% | -19.91% | -13.09% | -8.87% | -95.64% | |
| Return on Capital (ROIC) | -64.93% | -43.07% | -20.98% | -13.38% | -9.12% | -385.47% | |
| Earnings Yield | -490.37% | -127.25% | -79.75% | -11.27% | -1.79% | - | |
| FCF Yield | -437.67% | -109.28% | -61.38% | -9.18% | -2.38% | - | |
| Buyback Yield / Dilution | -0.98% | -0.76% | -2.20% | -208.53% | -235.50% | -2.82% | |
| Total Shareholder Return | -0.98% | -0.76% | -2.20% | -208.53% | -235.50% | -2.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.